3PBIOVIAN strengthens its Leadership team with the appointment of a Business Development Director for Advanced Therapies
News and updates
News
3PBIOVIAN receives the Talent Acceleration Award at the 2024 BWB Awards in Boston
3PBIOVIAN strengthens its executive team with the appointment of three new directors
Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO
3P Biopharmaceuticals: building a legacy of innovation and excellence in biotechnology
3P Biopharmaceuticals and the University of Navarra bring the Neanderthal world and biomedicine to the public in a successful event.
3P Biopharmecuiticals celebrates cerebral palsy day in collaboration with ASPACE
3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis.
3P Biopharmaceuticals lands in the United States.
3P Biopharmaceuticals continues its collaboration with U.S. biotech Zhittya for the treatment of Parkinson’s disease.
The Regional Minister for Economic and Business Development Mikel Irujo meets with the management of 3P Biopharmaceuticals and its majority shareholder Keensight Capital.
3P Biopharmaceuticals is moving forward with its expansion plan and the adaptation of its facilities.
3P Biopharmaceuticals increases its microbial production capacity with the installation of a 500 L fermenter.
3P Biopharmaceuticals among the 500 fastest growing companies in Spain
3P Biopharmaceuticals brings together leading international experts in biomedicine to celebrate its 15th anniversary.